Selected article for: "DE time point and time point"
Author: Josset, Laurence; Zeng, Hui; Kelly, Sara M.; Tumpey, Terrence M.; Katze, Michael G.
Title: Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options
  • Document date: 2014_2_4
    • ID: uz0m1o0q_9
    Snippet: In total, 16,327 genes were DE in at least one viral treatment and at one time point (Fig. 3B) . For each gene, we defined whether the gene was up-or downregulated during the course of infection or, for a minority of genes, had a transient expression pattern. Using this DE profile, the 16,327 DE genes were grouped in 25 clusters and functional enrichment was performed for each cluster (Table 1 ; see also Fig. S1 to S3 in the supplemental material.....
    Document: In total, 16,327 genes were DE in at least one viral treatment and at one time point (Fig. 3B) . For each gene, we defined whether the gene was up-or downregulated during the course of infection or, for a minority of genes, had a transient expression pattern. Using this DE profile, the 16,327 DE genes were grouped in 25 clusters and functional enrichment was performed for each cluster (Table 1 ; see also Fig. S1 to S3 in the supplemental material).

    Search related documents:
    Co phrase search for related documents
    • DE gene and expression pattern: 1, 2
    • DE gene and functional enrichment: 1
    • DE gene and supplemental material: 1
    • DE gene and time point: 1
    • DE gene and viral treatment: 1
    • expression pattern and functional enrichment: 1, 2, 3, 4
    • expression pattern and gene minority: 1
    • expression pattern and infection course: 1, 2, 3, 4, 5
    • expression pattern and supplemental material: 1, 2
    • expression pattern and time point: 1, 2, 3, 4
    • expression pattern and transient expression pattern: 1
    • expression pattern and viral treatment: 1
    • functional enrichment and infection course: 1
    • functional enrichment and supplemental material: 1
    • functional enrichment and time point: 1, 2, 3
    • functional enrichment and viral treatment: 1, 2, 3
    • infection course and supplemental material: 1, 2
    • infection course and time point: 1, 2, 3, 4, 5, 6, 7, 8
    • infection course and viral treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20